<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Research: Tina Giorgadze</title>
  <!-- site-wide styles -->
  <link rel="stylesheet" href="style.css" />
  <!-- page-specific styles -->
  <link rel="stylesheet" href="research.css" />
</head>
<body>

  <!-- same nav as other pages -->
  <nav>
    <div class="container">
      <a href="index.html">Home</a>
      <a href="teaching.html">Teaching</a>
      <a href="research.html" aria-current="page">Research</a>
      <a href="resume.pdf" target="_blank" rel="noopener">Resume (PDF)</a>
    </div>
  </nav>

  <header class="page-hero">
    <div class="container">
      <h1>Research experience</h1>
      <p>Abstracts, papers, and links to materials</p>
    </div>
  </header>

  <main>
    <div class="container">

      <!-- ===== 2025 ===== -->
      <h2 class="year-heading" id="y2025">2023 - present</h2>

      <!-- Example publication card -->
      <article class="pub card" itemscope itemtype="https://schema.org/ScholarlyArticle">
        <h3 class="pub-title">
          <a href="#" itemprop="url"><span itemprop="name">
            Inferring Copy Number States from Single-Cell Sequencing Data
          </span></a>
        </h3>
        <p class="pub-meta">
          <span class="authors" itemprop="author">T. Giorgadze, S. Tavare</span>
          <span class="dot">•</span>
          <span class="year" itemprop="datePublished">2024 - Present</span>
        </p>

        <div class="badges">
          <span class="badge">single-cell</span>
          <span class="badge">copy number</span>
          <span class="badge">statistical genomics</span>
        </div>

        <details class="abstract" open>
          <summary>Abstract</summary>
          <p itemprop="description">
            We present a framework for robust copy-number state inference in single-cell sequencing.
            Explicit likelihoods for the process seem impossible to compute, so we
propose to infer copy numbers using a random forest approach to Approximate
Bayesian Computation. This approach scales to realistic numbers of cells, and its
efficacy will be demonstrated by comparison to existing methods.
          </p>
        </details>

   <!--     <div class="pub-links">
          <a class="btn" href="#" target="_blank" rel="noopener">Paper</a>
          <a class="btn ghost" href="#" target="_blank" rel="noopener">PDF</a>
          <a class="btn ghost" href="#" target="_blank" rel="noopener">Code</a>
          <a class="btn ghost" href="#" target="_blank" rel="noopener">BibTeX</a>
        </div>
      </article> -->

      <!-- ===== 2023 ===== -->
      <h2 class="year-heading" id="y2023">2021-2023</h2>

      <article class="pub card" itemscope itemtype="https://schema.org/ScholarlyArticle">
        <h3 class="pub-title">
          <a href="#" itemprop="url"><span itemprop="name">
            Agent-Based Modeling of Cancer Immunotherapy
          </span></a>
        </h3>
        <p class="pub-meta">
          <span class="authors" itemprop="author">T. Giorgadze, H. Fischel, A. Tessier, K-A. Norton</span>
          <span class="dot">•</span>
          <span class="year" itemprop="datePublished">2023</span>
        </p>

        <div class="badges">
          <span class="badge">CAR-T Cell Therapy</span>
          <span class="badge">ABM</span>
          <span class = "badge"> Tumor Heterogeneity</span>
        </div>

        <details class="abstract">
          <summary>Abstract</summary>
          <p itemprop="description">
            Chimeric antigen receptor (CAR) T-cell therapy has shown much promise in liquid tumors but often fails in solid tumors. 
This work uses a computational model to examine under what conditions this therapy might fail or be successful. 
The model includes interactions between cancer cells, CAR T-cells (treatment), and vascular cells (that feed and support tumor growth).
 From our results, we determined specific tumor conditions in which CAR T-cell therapy is predicted to fail and suggest a combination 
treatment that might improve the efficacy of the treatment. Namely, we explore two forms of antigen expression in tumor cells: 
binary, and heterogeneous. 
          </p>
        </details>

        <div class="pub-links">
          <a class="btn" href="https://scholar.google.com/citations?view_op=view_citation&hl=en&user=EI9-75UAAAAJ&citation_for_view=EI9-75UAAAAJ:u5HHmVD_uO8C" target="_blank" rel="noopener">Paper - Binary expression</a>
          <a class="btn" href="https://scholar.google.com/citations?view_op=view_citation&hl=en&user=EI9-75UAAAAJ&citation_for_view=EI9-75UAAAAJ:u-x6o8ySG0sC" target="_blank" rel="noopener">Paper - Antigen Heterogeneity</a>
        </div>
      </article>

      <!-- add more year headings + .pub articles as needed -->

    </div>
  </main>

</body>
</html>
